Menu Search
Equities

Fagron NV

FAGR:BRU

Fagron NV

Actions
Health CareMedical Equipment and Services
  • Price (EUR)18.96
  • Today's Change0.16 / 0.85%
  • Shares traded69.77k
  • 1 Year change+11.86%
  • Beta0.3590
Data delayed at least 15 minutes, as of Nov 08 2024 16:37 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Fagron NV had little change in net income (from 69.61m to 70.55m) despite revenues that grew 11.57% from 683.88m to 762.99m. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 23.45% to 24.89%.
Gross margin44.17%
Net profit margin9.55%
Operating margin14.57%
Return on assets7.58%
Return on equity17.14%
Return on investment9.45%
More ▼

Cash flow in EURView more

In 2023, Fagron NV increased its cash reserves by 6.12%, or 7.67m. The company earned 124.63m from its operations for a Cash Flow Margin of 16.33%. In addition the company used 44.76m on investing activities and also paid 74.28m in financing cash flows.
Cash flow per share1.59
Price/Cash flow per share11.89
Book value per share6.48
Tangible book value per share-0.3247
More ▼

Balance sheet in EURView more

Fagron NV has a Debt to Total Capital ratio of 43.80%, a lower figure than the previous year's 86.11%.
Current ratio1.74
Quick ratio1.08
Total debt/total equity0.7862
Total debt/total capital0.438
More ▼

Growth rates in EUR

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 20.00% and 1.19%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked the highest relative to its industry peers.
Div yield(5 year avg)0.85%
Div growth rate (5 year)20.11%
Payout ratio (TTM)28.10%
EPS growth(5 years)10.18
EPS (TTM) vs
TTM 1 year ago		14.94
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.